EMBARC logo
Login

Lost your Password?

EMBARC

The European Bronchiectasis Registry


  • Home
  • About EMBARC 
    • What is EMBARC?
    • Steering Committee
    • International Advisory Board
    • Registry
    • Transparency Notice
    • EMBARC Members
    • Acknowledgements
  • NEWS 
    • Latest News
    • Newsletters 2019
    • Newsletters 2018
    • Newsletters 2017
    • Newsletters 2016
    • Newsletters 2015
  • RESEARCH 
    • Active projects
    • FRIENDS
    • Publications
    • Research Roadmap
  • EDUCATION 
    • Assessment and causes
    • Courses and Resources
    • Microbiology
    • NTM-lung
    • References
    • Severity assessment
    • Treatment
    • What is Bronchiectasis?
  • Patient Resource
  • Registry Documents 
    • EMBARC Registry
  • EMBARC Registry

Latest Research


Bronchiectasis: a case-based approach to investigation and management.

Contarini M, Finch S, Chalmers JD. / Eur Respir Rev. 2018 Jul 11;27(149). pii: 180016. doi: 10.1183/16000617.0016-2018. Print 2018 Sep 30. Review

US Patient-Centered Research Priorities and Roadmap for Bronchiectasis.

Henkle E, Aksamit TR, Daley CL, Griffith DE, O'Donnell AE, Quittner AL, Malanga E, Prieto D, Leitman A, Winthrop KL. / Chest. 2018 Nov;154(5):1016-1023. doi: 10.1016/j.chest.2018.06.032. Epub 2018 Jul 5.

Bronchiectasis and Multidrug-resistant Microorganisms: The Ideal Niche?

Mendez R, Amara I, Menendez R. / Arch Bronconeumol. 2018 Nov;54(11):543-544. doi: 10.1016/j.arbres.2018.02.018. Epub 2018 Jun 19. English, Spanish. No abstract available.

Moving forward: Bronchiectasis and chronic suppurative lung disease in children and adults in the 21st century.

Hill AT, Chang AB. / Respirology. 2018 Nov;23(11):1004-1005. doi: 10.1111/resp.13296. Epub 2018 Mar 25. Review. No abstract available

Bronchiectasis: new therapies and new perspectives

Chalmers JD, Chotirmall SH. / Lancet Respir Med. 2018 Sep;6(9):715-726. doi: 10.1016/S2213-2600(18)30053-5. Epub 2018 Feb 23. Review.

The BRICS (Bronchiectasis Radiologically Indexed CT Score): A Multicenter Study Score for Use in Idiopathic and Postinfective Bronchiectasis.

Bedi P, Chalmers JD, Goeminne PC, et al / Chest. 2018 May;153(5):1177-1186. doi: 10.1016/j.chest.2017.11.033. Epub 2017 Dec 13.

Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis.

Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Gerlinger C, Sotgiu G, Operschall E, Rutherford RM, Dimakou K, Polverino E, De Soyza A, McDonnell MJ / Am J Respir Crit Care Med. 2018 Jun 1;197(11):1410-1420. doi: 10.1164/rccm.201711-2202OC.

Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey.

Shteinberg M, Stein N, Adir Y, Ken-Dror S, Shitrit D, Bendayan D, Fuks L, Saliba W / Eur Respir J. 2018 May 10;51(5). pii: 1702469. doi: 10.1183/13993003.02469-2017. Print 2018 May.

Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis.

Choo JM, Abell GCJ, Thomson R, Morgan L, Waterer G, Gordon DL, Taylor SL, Leong LEX, Wesselingh SL, Burr LD, Rogers GB. / mSphere. 2018 Apr 18;3(2). pii: e00103-18. doi: 10.1128/mSphere.00103-18. Print 2018 Apr 25.

Blood Neutrophils are Reprogrammed in Bronchiectasis.

Bedi P, Davidson DJ, McHugh BJ, Rossi AG, Hill AT. / Am J Respir Crit Care Med. 2018 May 7. doi: 10.1164/rccm.201712-2423OC. [Epub ahead of print]
  • 1
  • 2
  • 3
  • 4
  • 5


Copyright ©2023 EMBARC. (ver: 1.7.3.4260)
Web Site Supported by HIC Services (University of Dundee) ©2023 ERS logo